What The FDA Guidance On Data Integrity Means For Your Lab
Source: Astrix Technology Group
By Dale Curtis Jr., President, Astrix Technology Group
Regulatory agencies worldwide are increasingly focusing their efforts on data integrity in GxP laboratories. This increased focus has led to a number of guidance documents being published on data integrity in 2016, including:
- The World Health Organization (WHO) published its final version of “Good Data and Records Management Practices” guidance document
- The European Medicines Agency (EMA) issued good manufacturing practice (GMP) guidance to ensure the integrity of data
- The Food and Drug Administration (FDA) issued a “Data Integrity and Compliance With cGMP” guidance document
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Laboratory Network? Subscribe today.
Subscribe to Laboratory Network
X
Subscribe to Laboratory Network
This website uses cookies to ensure you get the best experience on our website. Learn more